- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Reimbursement Provisions a Big Boost for the Diet Industry
The lack of attention by mainstream medicine to the problems of overweight or obese patients have contributed to the burgeoning diet industry.
As obesity is increasingly being recognized as the underlying cause of many a disease, healthcare plans have changed their approach to the condition, especially folowing a provision within the Affordable Care Act. Insurers are now mandated to cover nutrition and obesity screening for their enrollees.
This has created a tremendous opportunity for diet clinics and resulted in an industry of sorts, which sometimes uses as yet unproven treatments like vitamin injections or dietary supplements that may not have been validated. The lack of attention by mainstream medicine to the problems of overweight or obese patients may have contributed to the burgeoning diet industry, says an article in The New York Times.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Functional Similarity Between Ustekinumab Biosimilar ABP 654, Stelara in Crohn Disease
March 10th 2025Functional similarity of the ustekinumab biosimilar ABP 654 (Wezlana) and the reference product (Stelara) was confirmed by a series of in vitro studies, which support the totality of evidence for the biosimilar's FDA approval.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
